In adenocarcinomas, tricellulin immunoreactivities were more prominent than in normal regions, and the subcellular distribution of tricellulin varied depending on the degree of differentiation (Fig. 1a): In well-differentiated carcinoma components, localization of tricellulin was prominent in the cytoplasm and the plasma membrane. This evidence concerns the gene MARVELD2 and adenocarcinoma.